U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
NIMOTUZUMAB
INN   MI   WHO-DD  
INN  
Official Name English
THERALOC
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER
Common Name English
THERACIM-HR3
Code English
Nimotuzumab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULPHIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER
Common Name English
OSAG 101
Code English
NIMOTUZUMAB [MI]
Common Name English
nimotuzumab [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 01:53:48 GMT 2023 , Edited by admin on Sat Dec 16 01:53:48 GMT 2023
FDA ORPHAN DRUG 192504
Created by admin on Sat Dec 16 01:53:48 GMT 2023 , Edited by admin on Sat Dec 16 01:53:48 GMT 2023
NCI_THESAURUS C2167
Created by admin on Sat Dec 16 01:53:48 GMT 2023 , Edited by admin on Sat Dec 16 01:53:48 GMT 2023
EU-Orphan Drug EU/3/08/550
Created by admin on Sat Dec 16 01:53:48 GMT 2023 , Edited by admin on Sat Dec 16 01:53:48 GMT 2023
FDA ORPHAN DRUG 487915
Created by admin on Sat Dec 16 01:53:48 GMT 2023 , Edited by admin on Sat Dec 16 01:53:48 GMT 2023
Code System Code Type Description
MERCK INDEX
m7908
Created by admin on Sat Dec 16 01:53:48 GMT 2023 , Edited by admin on Sat Dec 16 01:53:48 GMT 2023
PRIMARY Merck Index
CAS
780758-10-3
Created by admin on Sat Dec 16 01:53:48 GMT 2023 , Edited by admin on Sat Dec 16 01:53:48 GMT 2023
PRIMARY
CAS
828933-51-3
Created by admin on Sat Dec 16 01:53:48 GMT 2023 , Edited by admin on Sat Dec 16 01:53:48 GMT 2023
SUPERSEDED
IUPHAR
7988
Created by admin on Sat Dec 16 01:53:48 GMT 2023 , Edited by admin on Sat Dec 16 01:53:48 GMT 2023
PRIMARY
NCI_THESAURUS
C2733
Created by admin on Sat Dec 16 01:53:48 GMT 2023 , Edited by admin on Sat Dec 16 01:53:48 GMT 2023
PRIMARY
MESH
C501466
Created by admin on Sat Dec 16 01:53:48 GMT 2023 , Edited by admin on Sat Dec 16 01:53:48 GMT 2023
PRIMARY
FDA UNII
6NS400BXKH
Created by admin on Sat Dec 16 01:53:48 GMT 2023 , Edited by admin on Sat Dec 16 01:53:48 GMT 2023
PRIMARY
INN
8545
Created by admin on Sat Dec 16 01:53:48 GMT 2023 , Edited by admin on Sat Dec 16 01:53:48 GMT 2023
PRIMARY
WIKIPEDIA
NIMOTUZUMAB
Created by admin on Sat Dec 16 01:53:48 GMT 2023 , Edited by admin on Sat Dec 16 01:53:48 GMT 2023
PRIMARY
DRUG BANK
DB06192
Created by admin on Sat Dec 16 01:53:48 GMT 2023 , Edited by admin on Sat Dec 16 01:53:48 GMT 2023
PRIMARY
EVMPD
SUB26699
Created by admin on Sat Dec 16 01:53:48 GMT 2023 , Edited by admin on Sat Dec 16 01:53:48 GMT 2023
PRIMARY
ChEMBL
CHEMBL2108359
Created by admin on Sat Dec 16 01:53:48 GMT 2023 , Edited by admin on Sat Dec 16 01:53:48 GMT 2023
PRIMARY
ACTIVE MOIETY
NIMOTUZUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966